BNET Industries
Guidant Corp. is in the Health Care Industry
Latest News and Analysis
Show Them The Door: 3 CEOs Who Need to Go
With the recent departures of Merrill Lynch CEO Stan O'Neal and Citigroup CEO Chuck Price,the question on everyone's mind is who will be the next to go. Today the Motley Fool is telling it straight by offering readers "3 CEOs Who Should Go." First up, Countrywide's Angelo...
Ascent Healthcare Receives 510 Clearances to Reprocess Coronary Bypass Devices from Guidant and Medtronic
PHOENIX -- Ascent Healthcare Solutions announced today that the U.S. Food and Drug Administration FDA has cleared two Ascent 510k submissions to reprocess specific Medtronic and Guidant cardiac stabilization and positioner devices.
Guidant Financial Group.(Awards & Honors)(Brief article)
Guidant Financial Group was honored by the U.S. Chamber of Commerce with the Small ... Guidant Financial Group was honored by the U.S. Chamber of Commerce with the Small Business of the Year award for the northwest and a Blue Ribbon Small Business award.
VentureNet Capital Group Announces Affiliation With Guidant Financial Group Professional Network
TEMECULA, Calif. -- VentureNet Capital Group, Inc. (Pink Sheets:VNTN) announced today its affiliation with Guidant Financial Group Professional Network.
Research and Markets: Guidant Corporation - Deals and Alliances Report Provide an Unbiased, Accurate, Independent Approach to Company Analysis, Whether for Partnering or Investment Purposes
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c51010) has announced the addition of "Guidant Corporation - Deals and Alliances Report" to their offering.
Research and Markets: The CRM and Cardiac Surgery Operations Were Gained by Boston Scientific's Much-Publicised US$27 Billion Merger with Guidant In April 2006, Where It Out-Bid Its Main Competitor, Johnson & Johnson
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c47830) has announced the addition of Boston Scientific Medical Device Company Intelligence Report from Espicom Business Intelligence to their offering.
With 18% revenue drop, Guidant unit drags down Boston Scientific growth.(Regulatory Report)
Boston Scientific says it will be another three to five years before it realizes double-digit growth from its acquisition of Guidant. Boston Scientific says it will be another three to five years before it realizes double-digit growth from its acquisition of Guidant.
Bioabsorble drug-eluting stent implanted in first human study.(MPMD)
Developed by Bioabsorbable Vascular Solutions, a Guidant subsidiary, the bioabsorbable everolimus-eluting stent is designed to be fully absorbed by vascular tissue following the restoration of blood flow in patients with coronary artery disease. The Developed by Bioabsorbable Vascular Solutions, a Guidant subsidiary, the bioabsorbable...
HONG KONG: GUIDANT PACEMAKERSRECALLED.
According to news.gov.hk: The Department of Health has advised patients implanted with heartbeat regulating devices manufactured by Guidant Hong Kong to contact their doctorsif they feel unwell. The manufacturer recalled the products after it found . According to news.gov.hk: The Department of Health has advised ...
Settlement Reached in Aspen Healthcare Metrics and Guidant Pricing Confidentiality Case
ATLANTA -- Aspen Healthcare Metrics and Guidant Sales Corporation have agreed to settle their court issues regarding pricing confidentiality and have reached mutually accepted settlement terms, which are confidential.
Boston Scientific, Guidant close the deal following FTC approval.(Regulatory Report)
Boston Scientific closed its $28 billion acquisition of Guidant on April 21, one day after the Federal Trade Commission approved the deal--the largest medical device acquisition in history. Boston Scientific closed its $28 billion acquisition of Guidant on April 21, one day after...
Abbott closes deal for Guidant biz.(Briefs)(Abbott Laboratories Inc.)(acquisition )(Brief article)
Abbott Laboratories closed its acquisition of Guidant's vascular intervention and endovascular businesses as Boston Scientific completed its deal to buy the rest of Guidant. Meanwhile, Abbott said first-quarter profit rose 3.2% as higher gross margin Abbott Laboratories closed its acquisition of Guidant's vascular intervention and...
Fitch Downgrades Boston Scientific Corp. to 'BBB' After Guidant Acquisition
CHICAGO -- Fitch Ratings has downgraded Boston Scientific Corp. BSX following today's completion of the company's $29 billion acquisition of Guidant Corp. (including approximately $90 million in interest paid to Guidant shareholders).
Boston Scientific Completes Combination With Guidant.
NATICK, Massachusetts, April 21 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed its combination with Guidant Corporation (NYSE: GDT), creating a global leader in cardiovascular devices and one of th NATICK, Massachusetts, April 21 /PRNewswire/ -- ...
Legg Mason getting a foot in the door.(Reverse Spin)
Byline: Frederick P. Gabriel Jr. It looks as if Legg Mason Inc. is about to get a real leg up on many of its competitors. Standard & Poor's in New York said Tuesday that the Baltimore...
Schaeffer's Midday Options Update Features Apple Computer, Microsoft, Monsanto, PMC-Sierra, and Guidant
CINCINNATI -- Today's Schaeffer's Midday Options Update features Apple Computer (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), Monsanto (NYSE:MON), PMC-Sierra (NASDAQ:PMCS), and Guidant (NYSE:GDT). The Midday Options Update contains a brief commentary on the day's most notable activity and a table listing the most-active calls and puts for the day. The Midday Options Update...
Guidant Announces Preliminary First Quarter 2006 Sales
INDIANAPOLIS -- Guidant Corporation (NYSE:GDT) today announced preliminary, unaudited first quarter revenues of approximately $894 million, reflecting a decline of approximately 6 percent versus the first quarter of 2005, and growth of 8 percent versus the fourth quarter of 2005. Preliminary, unaudited U.S. and worldwide implantable defibrillator sales for the...
Guidant focused on trend thresholds instead of preventable deaths--panel.(Regulatory Report)
Guidant has relied too much on engineers and not enough on physicians in evaluating the postmarket performance of its implantable cardiac rhythm management products, making it possible for device problems to go unaddressed, according to an expert pan Guidant has relied too much on engineers and...
Guidant to Temporarily Suspend XIENCE V Supply; Company Expects European Launch of XIENCE V in Third Quarter 2006
INDIANAPOLIS -- Guidant Corporation (NYSE:GDT) today announced that a small percentage (approximately 1 percent) of the current XIENCE V inventory was not manufactured with strict adherence to its quality standards. To maintain the highest level of quality assurance, Guidant has decided not to release current XIENCE V inventory.
Medtronic Sues Guidant in Ireland; Alleges Patent Infringement by Vision® and Xience™ Stents; Seeks Damages and Injunction
MINNEAPOLIS -- Medtronic, Inc. (NYSE:MDT) today announced that it has filed a patent infringement lawsuit against Guidant Corporation in the High Court in Dublin, Ireland. The lawsuit alleges that the Guidant MULTI-LINK VisionR and XienceTM V coronary stents infringe patents under exclusive worldwide license to Medtronic Vascular from evYsio Medical...
- Next »
- page 1 of 43
- « Previous
Sort byClose
View by Content TypeClose
View Related Content by Tag Close
- FDA (60 results)
- patient (47 results)
- Johnson & Johnson (35 results)
- sales (32 results)
- stock (27 results)
- physician (25 results)
- health care (24 results)
- Boston Scientific Corp. (24 results)
- clinical trial (21 results)
- acquisition (21 results)
- medical device (20 results)
- therapy (16 results)
- dividend (15 results)
- Webcast (15 results)
- board (15 results)
- agreement (15 results)
- Microsoft Windows CE (14 results)
- S&P (11 results)
- earnings per share (11 results)
- class action (10 results)
- S&P 500 (10 results)
- Medtronic Inc. (9 results)
- stock market (9 results)
- merger (9 results)
- benefit (7 results)
- board of directors (7 results)
- Nortel Networks Corp. (7 results)
- performance (7 results)
- SBC Communications Inc. (7 results)
- shareholder (7 results)
- API (7 results)
- industry (6 results)
- equity (5 results)
- Fitch (5 results)
- insurance (5 results)
- women (5 results)
- Medicare (5 results)
- Company (5 results)
- Merrill Lynch & Co. Inc. (5 results)
- multimedia (4 results)
- United States Steel Corp. (4 results)
- leader (4 results)
- New York Stock Exchange (4 results)
- equity investment (3 results)
- Pivotal Corp. (3 results)
- FTC (3 results)
- European Commission (3 results)
- El Paso Corp. (3 results)
- job (3 results)
- financial (3 results)